SequelSEC

GP-Act III Acquisition Corp. GPAT

Blank Checks · CIK 0001834526 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$551.92K
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

GP-Act III Acquisition Corp. (GPAT) reported net income of $11.89M for the fiscal year ended 2025-12-31. This page shows 3 annual periods of income statement, balance sheet and cash flow figures normalized from GP-Act III Acquisition Corp.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Blank Checks.

Income

GP-Act III Acquisition Corp. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
RevenueUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailable
Operating income-$551.92K-$564.97K-$14.04K
Net income$11.89M$8.67M-$14.04K
Research & developmentUnavailableUnavailableUnavailable
Weighted-average diluted sharesUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailable
General & administrative$551.92K$564.97K$14.04K
Selling & marketingUnavailableUnavailableUnavailable

Balance

GP-Act III Acquisition Corp. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Cash & equivalentsUnavailableUnavailable$1.21K
Total assets$309.37M$297.47M$530.24K
Current assets$188.11K$675.36K$3.31K
Total liabilities$14.67M$14.67M$628.18K
Current liabilities$634.61K$631.60K$628.18K
Total equity incl. NCI-$14.48M-$13.93M-$97.94K
Temporary (mezzanine) equity$309.18M$296.74MUnavailable
InventoryUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailable

Cash flow

GP-Act III Acquisition Corp. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Operating cash flow-$372.22K-$584.72K-$10.97K
Capital expendituresUnavailableUnavailableUnavailable
Investing cash flowUnavailable-$287.50MUnavailable
Financing cash flow$1.31K$288.57M$10.42K
Net change in cashUnavailableUnavailableUnavailable
Stock-based compensationUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailable

Derived

GP-Act III Acquisition Corp. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Free cash flowUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailable
Current ratio0.30x1.07x0.01x
Revenue YoY growthUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GPAT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-26View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

AACI AACO ADAC AEAQ AESP AEXA AFJK AIIA ALCYF ALDA ALDF ALFUU

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.